Answers are grounded in this paper and cite their sources.
This analysis shows a sensitive aptasensor detecting lung-specific biomarkers, highlighting its specificity and stability.
Abstract This work was focused on development a stable, selective and sensitive electrochemical aptasensor based on 3,4,9,10-perylene tetracarboxylic acid -functionalized chemical converted graphene (PTCA/CCG) modified electrode for monitoring neuron specific enolase (NSE), lung-specific biomarkers. The electrochemical aptasensor was relied on the purified NSE aptamer immobilized on PTCA/CCG modified electrode. The PTCA/CCG promoted both the immobilization of the aptamer and the electrochemical signal. The aptasensor exhibited a low limit of detection (0.008 ng/mL), broad linear range (10⁻ ³ to 10³ ng/mL), remarkable specificity, and excellent repeatability and long-term stability, maintaining initial resistance at 96.57% after 30 days. Results exhibited that the recoveries ranging from 98.00–99.00% and relative standard deviation less than 4.08%, demonstrating the acceptable precision and reliability of the fabricated aptadensor and confirming the aptasensor's performance and efficiency in complex biological fluids and clinical applications.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: